{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T21:19:39Z","timestamp":1771017579243,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.biopha.2004.09.006","type":"journal-article","created":{"date-parts":[[2004,10,14]],"date-time":"2004-10-14T11:19:00Z","timestamp":1097752740000},"page":"582-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients"],"prefix":"10.1016","volume":"58","author":[{"given":"Ayca","family":"Kaya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neslihan","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u0131nar","family":"Topsever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00fcge","family":"Filiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arslan","family":"Da\u011far","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ebru","family":"K\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cem","family":"Ekmekcioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2004.09.006_bib1","series-title":"Clinical obesity","first-page":"10","article-title":"Epidemiology; definition and classification of obesity","author":"Seidel","year":"1998"},{"key":"10.1016\/j.biopha.2004.09.006_bib2","unstructured":"World Health Organization 1990 Report of the WHO Study Group: diet, nutrition and prevention of chronic diseases, Geneva: WHO; 1990. WHO Technical Report Series 797."},{"key":"10.1016\/j.biopha.2004.09.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-199400051-00003","article-title":"Worldwide epidemiology of obesity","volume":"5","author":"Van\u00a0Itallie","year":"1994","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.biopha.2004.09.006_bib4","first-page":"12","article-title":"obesity epidemic puts millions at risk from related diseases","volume":"46","year":"1997","journal-title":"Press Release WHO"},{"key":"10.1016\/j.biopha.2004.09.006_bib5","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1093\/ije\/18.3_Supplement_1.S46","volume":"18","year":"1989","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.biopha.2004.09.006_bib6","first-page":"43","article-title":"The role of obesity in diabetes","volume":"16","author":"Turner","year":"1992","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2004.09.006_bib7","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/oxfordjournals.aje.a115686","article-title":"Weight as a risk factor for clinical diabetes in women","volume":"132","author":"Colditz","year":"1990","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.biopha.2004.09.006_bib8","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study","volume":"67","author":"Hubert","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2004.09.006_bib9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1001\/jama.1997.03540430051032","article-title":"A prospective study of body mass index, weight change and risk of stroke in women","volume":"277","author":"Rexrode","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.biopha.2004.09.006_bib10","unstructured":"WHO 2000. Obesity: preventing and managing the global epidemic. Report of a WHO consultation, Geneva: WHO; 2000. WHO Technical Report Series 894."},{"key":"10.1016\/j.biopha.2004.09.006_bib11","first-page":"S38","article-title":"Sibutramine and fat distribution: is there a role for pharmacotherapy in abdominal\/visceral fat reduction?","volume":"22","author":"Van\u00a0Gaal","year":"1998","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2004.09.006_bib12","first-page":"58","article-title":"Confronting the failure of behavioural and dietary treatments of obesity","volume":"6","author":"Garner","year":"1991","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.biopha.2004.09.006_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ijo.0800540","article-title":"Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study","volume":"22","author":"Hanotin","year":"1998","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2004.09.006_bib14","series-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics. 10 ed","first-page":"260","article-title":"5-Hydroxytriptamine serotonin: receptor agonists and antagonists","author":"Bush","year":"2001"},{"key":"10.1016\/j.biopha.2004.09.006_bib15","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1345\/aph.19412","article-title":"Orlistat\u2014a novel weight loss therapy","volume":"35","author":"Lucas","year":"2001","journal-title":"Ann. Pharmacother"},{"key":"10.1016\/j.biopha.2004.09.006_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1520-7560(200003\/04)16:2<114::AID-DMRR97>3.0.CO;2-O","article-title":"Antiobesity pharmacotherapy in the management of type 2 diabetes","volume":"16","author":"Scheen","year":"2000","journal-title":"Diabet Metab Res Rev"},{"key":"10.1016\/j.biopha.2004.09.006_bib17","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2337\/diacare.21.8.1288","article-title":"Role of orlistat in the treatment of obese patient with type 2 diabetes; a 1-year randomized double-blind study","volume":"21","author":"Hollander","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopha.2004.09.006_bib18","first-page":"57","volume":"4083","year":"1998","journal-title":"Evidence Report. NIH Publications"},{"key":"10.1016\/j.biopha.2004.09.006_bib19","series-title":"Statistics with confidence. 2nd ed","first-page":"208","article-title":"Computer software for calculating confidence intervals CIA","author":"Bryant","year":"2001"},{"key":"10.1016\/j.biopha.2004.09.006_bib20","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/j.1550-8528.1996.tb00544.x","article-title":"A double-blind randomized placebo-controlled trial of sibutramine","volume":"4","author":"Bray","year":"1996","journal-title":"Obes. Res."},{"key":"10.1016\/j.biopha.2004.09.006_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/j.1550-8528.1999.tb00701.x","article-title":"Sibutramine produces dose-related weight loss","volume":"7","author":"Bray","year":"1999","journal-title":"Obes. Res."},{"key":"10.1016\/j.biopha.2004.09.006_bib22","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/sj.ijo.0801814","article-title":"The effects of orlistat on weight and on serum lipids in obese patients with hypercholesterolaemia: a randomized, double blind, placebo-controlled, multicentre study","volume":"25","author":"Muls","year":"2001","journal-title":"Int. J. Obes. Relat. Metab. Disorder"},{"key":"10.1016\/j.biopha.2004.09.006_bib23","first-page":"1","article-title":"A rapid and systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity","volume":"5","author":"O\u2019Meara","year":"2001","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.biopha.2004.09.006_bib24","first-page":"49","article-title":"Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity","volume":"4","author":"Gokcel","year":"2002","journal-title":"Diabet. Res. Metab."},{"key":"10.1016\/j.biopha.2004.09.006_bib25","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/oby.2000.53","article-title":"Effects of sibutramine plus orlistat in obese women following 1 year of treatment by sibutramine alone: a placebo-controlled trial","volume":"8","author":"Wadden","year":"2000","journal-title":"Obes. Res."},{"key":"10.1016\/j.biopha.2004.09.006_bib26","first-page":"530","article-title":"Sibutramine\u2014a review of clinical efficacy","volume":"21","author":"Lean","year":"1997","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.biopha.2004.09.006_bib27","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)03491-7","article-title":"effects of sibutramine on weight maintenance after weight loss: a randomized trial","volume":"356","author":"James","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2004.09.006_bib28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0002-9343(98)00411-2","article-title":"Long-term maintenance of weight loss after a very-low-calorie diet: a randomized blinded trial of the efficacy and tolerability of sibutramine","volume":"106","author":"Apfelbaum","year":"1999","journal-title":"Am. J. Med."},{"key":"10.1016\/j.biopha.2004.09.006_bib29","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1345\/aph.18319","article-title":"Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity","volume":"33","author":"Luque","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.biopha.2004.09.006_bib30","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/sj.ijo.0801128","article-title":"One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor","volume":"24","author":"Finer","year":"2000","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.biopha.2004.09.006_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s002280050433","article-title":"Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat dose-ranging study group","volume":"54","author":"Van\u00a0Gaal","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2004.09.006_bib32","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1097\/00004872-199816121-00024","article-title":"Treatment with orlistat reduces cardiovascular risk in obese patients","volume":"16","author":"Zavoral","year":"1998","journal-title":"J. Hypertens."},{"key":"10.1016\/j.biopha.2004.09.006_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomized placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicenter Orlistat Study Group","volume":"352","author":"Sjostrom","year":"1998","journal-title":"Lancet"}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332204001532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332204001532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:34:36Z","timestamp":1760092476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332204001532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0753332204001532"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2004.09.006","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2004.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}